Home LiteratureArticle Details
PMID: 10611203 Published · ppublish English Case Reports Journal Article

A normal livebirth after intracytoplasmic sperm injection for globozoospermia without assisted oocyte activation: case report.

Human reproduction (Oxford, England) ·Vol. 15 ·No. 1 ·2000-01-00 ·Pages 139-41

Stone S, O'Mahony F, Khalaf Y, Taylor A, Braude P

Abstract

The successful outcome of intracytoplasmic sperm injection (ICSI) with round-headed spermatozoa (globozoospermia) is reported. A couple with infertility secondary to globozoospermia received ICSI treatment. Fertilization, cleavage and pregnancy outcomes were recorded. This couple experienced 40, 10 and 42% fertilization rates after ICSI in their first, second and third cycles respectively. Pregnancy did not occur in the first or second cycle but was successfully achieved after the third ICSI cycle. It is concluded that current ICSI procedures may overcome the infertility associated with globozoospermia and result in normal healthy livebirth without assisted oocyte activation.

MeSH Terms
Adult Female Humans Infertility, Male/pathology,therapy Male Microscopy, Electron Oocytes/physiology Pregnancy Sperm Head/ultrastructure Sperm Injections, Intracytoplasmic Sperm Tail/ultrastructure Spermatozoa/abnormalities,ultrastructure Treatment Outcome
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Stone S
Assisted Conception Unit, Guy's and St Thomas' Hospitals Trust, Lambeth Palace Road, London SE1 7EH, UK.
O'Mahony F
Khalaf Y
Taylor A
Braude P
Article Info
Journal
Human reproduction (Oxford, England)
Abbr.
Hum Reprod
ISSN
0268-1161
Published
2000-01-00
Pages
139-41
Language
English
Region
England
NLM ID
8701199
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]